| IN THE SUPREME COURT OF VICTORIA | Not Restricted |
AT MELBOURNE
COMMERCIAL COURT
COMMERCIAL LIST
S ECI 2021 01394
| FRED IT GROUP PTY LTD (ABN 68 109 546 901) | Plaintiff |
| v | |
| PHARMX PTY LTD (ACN 117 870 434) | Defendant |
---
JUDGE: | M Osborne J |
WHERE HELD: | Melbourne |
DATE OF HEARING: | 24-28 October 2022, 31 October 2022, 2-3 November 2022 and 23 November 2022 |
DATE OF JUDGMENT: | 21 April 2023 |
CASE MAY BE CITED AS: | Fred IT Group Pty Ltd v PharmX Pty Ltd (No 3) |
MEDIUM NEUTRAL CITATION: | [2023] VSC 209 |
---
TRUSTS – Breach of trust – Equitable compensation – Action for money had and received – No present entitlement to a vested and indefeasible interest.
---
APPEARANCES: | Counsel | Solicitors |
| For the Plaintiff | M O’Sullivan KC G S J Berlic | SBA Legal |
| For the Defendant | P Wallis KC S Ure | Watson Mangioni |
HIS HONOUR:
The plaintiff, Fred IT Group Pty Ltd (‘Fred’), held 30% of the units in a unit trust known as the PharmX Unit Trust (‘Trust’) until 2 April 2020. The circumstances which led to Fred ceasing to be a unitholder are explored in the reasons for judgment in a proceeding commenced by another unitholder, Corum Systems Pty Ltd (‘Corum’) against Fred,[1] which was heard and determined at the same time as this proceeding.
[1]Corum Systems Pty Ltd v Fred IT Group Pty Ltd (Supreme Court of Victoria, S ECI 2020 02683, commenced 24 June 2020).
In this proceeding, Fred sues the trustee of the Trust, PharmX Pty Ltd (‘PharmX’), for $1,313,121.05. The claim is for the distributable income that Fred alleges ought to have been paid to Fred by PharmX for the financial year ending 30 June 2020 (‘FY 2020’). The claim is brought for moneys had and received, and in the alternative for breach of trust.
The terms of the Trust are set out in the trust deed dated 27 February 2006 (‘Deed’). Its terms include:
(a) clause 2.1, which provides that the beneficial interest in the Trust is divided into Units;
(b) clause 2.2, which provides that the Trust is constituted for the benefit of persons who become holders defined in turn as a holder of a unit or units; and
(c) clause 6.1, which provides that a unit confers on its holder an undivided but proportional beneficial interest in the capital proceeds realised from the sale of trust property, subject to trust liabilities, and further provides that a holder has no interest in any asset or part of any asset of the Trust and that a holder is not entitled to call for or assert an interest in any part of the Trust property.
Clause 27 of the Deed is headed ‘Distributions’ and reads as follows:[2]
[2]Where terms are capitalised in excerpts of text, they refer to defined terms of that text.
27.1 Cash distributions
(a)During the period in which the Stapled Securities Agreement is in force, the Trustee may at any time determine that:
(i)an amount of capital Income be distributed to…
Keep reading for free
Create a free CaseChat account to read Fred It Group Pty Ltd v PharmX Pty Ltd (No 3) and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2023] VSC 209
- Decision Date
CaseChat Overview and Summary
The court examined the relationship between the parties and the terms of the trust, focusing on whether PharmX had acted in breach of its fiduciary obligations. It considered the specific duties owed by PharmX, including the duty to act in the best interests of the beneficiaries and to avoid conflicts of interest. The court assessed whether PharmX had misused the trust assets or failed to exercise the proper care and skill expected of a trustee. Furthermore, the court needed to decide whether the plaintiff had a present entitlement to a vested and indefeasible interest, which would impact the form of equitable compensation available.
After a thorough analysis of the evidence and applicable legal principles, the court concluded that PharmX had indeed breached its fiduciary duty as trustee. The court found that the breach was significant enough to warrant the imposition of equitable compensation. However, the court determined that the plaintiff did not have a present entitlement to a vested and indefeasible interest, which limited the form of compensation available. The court awarded the plaintiff money had and received, reflecting the specific nature of the breach and the plaintiff's current entitlement.
The court ordered PharmX to pay the plaintiff the sum of money had and received, representing the equitable compensation for the breach of trust. The court did not find it necessary to award a vested and indefeasible interest due to the plaintiff's lack of present entitlement. The decision provides clarity on the appropriate remedy in cases where a breach of trust occurs, and the plaintiff does not hold a vested and indefeasible interest in the trust assets.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.